Loading...
The restricted mean survival time as a replacement for the hazard ratio and the number needed to treat in long‐term studies
AIMS: We applied the restricted mean survival time (RMST) to analyse the survival data reported in the PARADIGM‐HT trial in which sacubitril + valsartan was studied in comparison with enalapril in patients with heart failure. The estimates of this parameter were compared with the published values of...
Na minha lista:
| Udgivet i: | ESC Heart Fail |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120383/ https://ncbi.nlm.nih.gov/pubmed/33733623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13306 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|